Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-16-002650
Filing Date
2016-02-16
Accepted
2016-02-16 16:12:23
Documents
1
Group Members
DEERFIELD INTERNATIONAL MASTER FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.

Document Format Files

Seq Description Document Type Size
1 e614648_sc13g-tribute.htm SC 13G 373008
  Complete submission text file 0001193805-16-002650.txt   374714
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Subject) CIK: 0001159019 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79704 | Film No.: 161428278
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G